NASDAQ: Tech

Bio-Techne Leverages the RNAscope Technology to Advance a Multiomic Approach to Antibody Validation

MINNEAPOLIS, Oct. 7, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, has been validating a growing number of immunohistochemistry (IHC) antibodies using the Advanced Cell Diagnostics-branded RNAscope in situ hybridization (ISH) platform to leverage its transcriptomics approach […]

Bio-Techne Receives Approval to Offer the ExoDx™ Prostate Intelliscore™ (EPI) Test in New York State

The EPI prostate biopsy rule-out test is now available in every state MINNEAPOLIS, June 13, 2019 /PRNewswire/ — Bio-Techne today announced that it has received a clinical laboratory permit from the New York State Department of Health to provide its ExoDx Prostate IntelliScore (EPI) test in New York, providing a valuable tool to help Urologists […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER